---
title: Overview
date: 2018-09-15T07:42:34.000+00:00
slug: overview

---
## First line information about COVID-19

## CLINICAL GUIDES/GENERAL INFO

* [**COVID One Pager**](https://www.onepagericu.com/)
* [**EmCrit COVID Review**](https://emcrit.org/ibcc/covid19/)
* [**CDC COVID Site**](https://www.cdc.gov/coronavirus/2019-ncov/)
* [**EB Medicine COVID19 Guide**](https://www.ebmedicine.net/topics/infectious-disease/COVID-19)
* [**UpToDate COVID19**](https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-epidemiology-virology-and-prevention)

## EPIDEMIOLOGY

Patient Characteristics:

* Median hospitalised age varies by country and case report, mostly between 40s-70s ([**Wang et al**](https://www.ncbi.nlm.nih.gov/pubmed?term=32031570), [**Arentz et al**](https://jamanetwork.com/journals/jama/fullarticle/2763485))
* Initial male predominance but less clear as more data appears ([**Wang et al**](https://www.ncbi.nlm.nih.gov/pubmed?term=32031570), [**Arentz et al**](https://jamanetwork.com/journals/jama/fullarticle/2763485))
* Most patients with comorbidities, esp HTN, DM, CVD, chronic respiratory disease Incubation period: median 5-7 days, 98% within 12 days ([**Lauer et al**](https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported), [**Tian et al**](https://www.journalofinfection.com/article/S0163-4453(20)30101-8/fulltext)) R0: around 2-2.5 in general population ([**WHO**](https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-sitrep-46-covid-19.pdf)), up to 11 aboard cruise ships ([**Mizumoto & Chowell**](https://www.sciencedirect.com/science/article/pii/S2468042720300063)) but can be lowered through distancing & public health controls Viral shedding: can be present 1-3 days prior to onset of symptoms, median duration 20 days with durations up to 37 days in recovered patients ([**Zhou et al**](https://www.ncbi.nlm.nih.gov/pubmed/32171076/))

### Transmission:

* Transmission via droplet, contact (fomites up to 7hrs on some surfaces); unclear if airborne transmission but may be possible ([**van Doremalen et al**](https://www.nejm.org/doi/full/10.1056/NEJMc2004973)) Asymptomatic transmission appears to occur based on case reports ([**Bai et al**](https://jamanetwork.com/journals/jama/fullarticle/2762028), [**Rothe et al**](https://www.nejm.org/doi/full/10.1056/NEJMc2001468)) and may be the source of a majority of infections based on modeling (Li et al)

### ISOLATION & PPE

* Current CDC, WHO, SCCM recommendations: contact and droplet for COVID+ and rule out; airborne if aerosolizing procedure
  * In influenza studies, surgical facemasks appear equivalent to N95 in respiratory infection prevention -- though N95 significantly better in vitro, pragmatic benefit unclear ([**Smith et al**](https://pubmed.ncbi.nlm.nih.gov/26952529/), [**Radonovich et al**](https://jamanetwork.com/journals/jama/fullarticle/2749214))
* All aerosolizing procedures (intubation, NIPPV, HFNC, suctioning, nebs, bronchoscopy, endoscopy, TEE) should be performed in negative pressure rooms ([**SCCM**](https://www.sccm.org/Blog/January-2020/Caring-for-Critically-Ill-Patients-with-Novel-Coro))
  * HFNC increases droplet spread and should be considered aerosolizing ([**Ne-Hooi et al**](https://link.springer.com/article/10.1007%2Fs12630-020-01634-3))
  * Laparoscopy should be considered a potentially aerosolizing procedure and viral filters should be used, avoid ALL elective procedures ([**SAGES**](https://www.sages.org/recommendations-surgical-response-covid-19/))
  * Avoid aerosolizing procedures when possible
* [**University of Nebraska UV mask decontamination protocol**](https://www.nebraskamed.com/sites/default/files/documents/covid-19/n-95-decon-process.pdf)
* PPE Distribution Sites working to match HCWs needing PPE with people looking to donate: [**Get Us PPE**](https://getusppe.org/) [**Project N95 National COVID PPE Clearinghouse**](https://www.projectn95.com/) [**MaskMatch**](https://www.mask-match.com/)

#### Creative solutions as supplies run low:

##### 3D printing templates (not tested or validated, but likely better than nothing)

* [**Masks, face shields**](https://github.com/scaleworkspace/covid19)
* [**Dual filter masks**](https://www.thingiverse.com/thing:4232209)
* [**Face shields**](https://blog.prusaprinters.org/from-design-to-mass-3d-printing-of-medical-shields-in-three-days/)
* [**Face mask holders/frames**](https://www.thingiverse.com/thing:4141338) (maybe with vacuum bags/HEPA filters inside?)

#### Masks

Masks

N95s > surgical masks >>> homemade cloth masks > nothing against droplet transmission ([**MacIntyre et al**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420971/?fbclid=IwAR0l8pDr_lbIc08Si_V0ArBf_7I-xunS1kb2MAfifS56Z9yiL2Aao6020yw#__ffn_sectitle), [**van der Sande et al**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440799/))

2015 large, prospective randomized control trial of cloth masks vs clinical masks. Relative risk of 13 for influenza-like illnesses in healthcare workers wearing cloth masks vs. standard clinical masks. ([**MacIntyre et al**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420971/?fbclid=IwAR0l8pDr_lbIc08Si_V0ArBf_7I-xunS1kb2MAfifS56Z9yiL2Aao6020yw#__ffn_sectitle))

### _CLINICAL FEATURES_

### Symptoms

#### Adults

Fever (99% over 99F in one study, but up to 40% afebrile on admission in another), fatigue (70%), dry cough (59%), anorexia (40%), myalgias (35%), dyspnea (31%), sputum production (27%) ([**Wang et al**](https://jamanetwork.com/journals/jama/fullarticle/2761044), [**Leung et al**](https://onlinelibrary.wiley.com/doi/10.1002/rmv.2103), [**Arentz et al**](https://jamanetwork.com/journals/jama/fullarticle/2763485), [**Guan et al**](https://www.nejm.org/doi/full/10.1056/NEJMoa2002032))

* Symptoms are highly variable and should generally have high index of suspicion for isolation and testing ([**Lynch**](https://edhub.ama-assn.org/jn-learning/audio-player/18315876))
* Look out for “silent hypoxemia” -- profound hypoxemia without respiratory distress ([**Xie et al**](https://link.springer.com/article/10.1007%2Fs00134-020-05979-7))
* GI symptoms (abd pain, diarrhea, N/V) were rare in some case series but common (49%) in others; often preceded respiratory symptoms ([**Wang et al**](https://jamanetwork.com/journals/jama/fullarticle/2761044), [**Lei et al**](https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf))
* May present with anosmia per European reports, though unable to find original case reports ([**ENT UK**](https://www.entuk.org/loss-sense-smell-marker-covid-19-infection))
* ARDS present in all intubated patients [**Arentz et al**](https://jamanetwork.com/journals/jama/fullarticle/2763485)
* Cardiomyopathy in ⅓ of patients ([**Arentz et al**](https://jamanetwork.com/journals/jama/fullarticle/2763485), [**Ruan et al**](https://link.springer.com/article/10.1007/s00134-020-05991-x))
* Presence of shock highly variable (1%-35%) ([**SCCM**](https://www.sccm.org/Blog/January-2020/Caring-for-Critically-Ill-Patients-with-Novel-Coro))

#### Children

More variable -- most common cough (48%), pharyngeal erythema (46%), fever (42%) ([**Lu et al**](https://www.nejm.org/doi/full/10.1056/NEJMc2005073))

#### Pregnancy

Very little known, but very small (15) case series without clear difference in outcomes of mild disease or clear adverse impact on fetus/childbirth ([**Liu et al**](https://www.ajronline.org/doi/10.2214/AJR.20.23072))

* If you have a pregnant patient, please refer for the [**PRIORITY study**](https://priority.ucsf.edu/) to help us learn more about symptoms & outcomes in pregnancy

### _WHO_

[**WHO Global Database**](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov?fbclid=IwAR1aaZk1fODdOJZI2LiBqStQaxOrMJLcrvkEo37Santk_Mq59pCcCA9yn8g)

[**Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)**](https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf)

### _Medscape_

[**Medscape COVID**](https://www.medscape.com/resource/coronavirus)

### _UpToDate_

[**UpToDate**](https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19)

### **_Guidelines_**

* [**Massachusetts General Hospital**](https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19)
* [**Mount Sinai**](https://www.mountsinai.org/files/MSHealth/Assets/HS/About/Coronavirus/MountSinaiHealthSystem-TreatmentGuidelines-COVID-3-17.pdf)
* [**COVID-19 Chinese Consultation Center Release**](https://covid-19.alibabacloud.com/)
* [**WHO**](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance)
* [**COVID One Page**](https://www.onepagericu.com/)

#### **_Overviews_**

* [**EmCrit**](https://emcrit.org/ibcc/covid19/)
* [**EB Medicine**](https://www.ebmedicine.net/topics/infectious-disease/COVID-19)
* [**Medscape**](https://www.medscape.com/resource/coronavirus)
* [**Seattle Intensivist One Page Summary**](https://www.kevinmd.com/blog/2020/03/an-intensivists-one-pager-on-covid-19.html)
* [**CDC for healthcare professionals**](https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html?fbclid=IwAR3AKR7294gMyD4eqseI2dgkKd5VgUE6OdM3VJwNmEuWZST3EnTE8D7yZhA)

#### **_Personal Protective Equipment (PPE)_**

[**CDC: Desinfection FFP**](https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html)

[**Ann Occup Hyg: Evaluation of Five Decontamination Methods for Filtering Facepiece Respirators**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781738/)

[**Association between 2019-nCoV transmission and N95 respirator use**](https://www.journalofhospitalinfection.com/article/S0195-6701(20)30097-9/fulltext)

[**Ultraviolet Germicidal Irradiation (UVGI) on N95 Respirator**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699414/)

### **_Articles_**

[**NEJM Re**](https://www.nejm.org/coronavirus?query=RP)**source gathering**

[**LitCovid literature hub**](https://www.ncbi.nlm.nih.gov/research/coronavirus/?fbclid=IwAR2WTLb7tB3S6rrwGS1d-hOS6FlYDYPjt_vOEhK6F_hca4shvIkEtXEvKxA)

#### Virology

[**NEJM: SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients**](https://www.nejm.org/doi/10.1056/NEJMc2001737)

[**COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism**](https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173)

[**Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture**](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973827/)

#### Diagnostics

[**Journal of Infection: Profile of Specific Antibodies to SARS-CoV-2: The First Report**](https://www.journalofinfection.com/article/S0163-4453(20)30138-9/fulltext)

#### Farmacology

[**EMA: NSAID and COVID-19**](https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19)

[**Renin-Angiotensin System Blockers and the COVID-19 Pandemic**](https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.15082)

[**NEJM: Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19**](https://www.nejm.org/doi/full/10.1056/NEJMsr2005760?query=featured_home)

#### Genetics

[**The COVID-19 Genetics Host Initiative**](https://www.covid19hg.com/)

#### Health care workers

[**JAMA: Supporting the Health Care Workforce During the COVID-19 Global Epidemic**](https://jamanetwork.com/journals/jama/fullarticle/2763136)

#### Epidemiology och disease control

[**Lancet: Estimates of the severity of coronavirus disease 2019: a model-based analysis**](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext)

[**BMJ: Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village**](https://www.bmj.com/content/368/bmj.m1165)

[**Imperial College: Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries**](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf?fbclid=IwAR0hBXPiFmItCWZcxMFhUFdqTLV6-yMj4XFmgILGPpgF5SVDDGZA1UG-bBQ)

[**Imperial College: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand**](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf)

[**medRxiv: Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study**](https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1)

[**Lancet: COVID-19: learning from experience**](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30686-3/fulltext)

#### Risk factors

[**BMJ: Covid-19: risk factors for severe disease and death**](https://www.bmj.com/content/368/bmj.m1198)

[**Obesity: High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation**](https://onlinelibrary.wiley.com/doi/abs/10.1002/oby.22831)

#### **_Clinical Trials_**

[**Global dashboard ongoing tr**](https://www.quiverquant.com/covidtreatments/)**ials**

[**Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19**](https://clinicaltrials.gov/ct2/show/NCT04323800?cond=Covid-19&draw=2&rank=100)

[**Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NOSARSCOVID)**](https://clinicaltrials.gov/ct2/show/NCT04290871)

[**The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection**](https://academic.oup.com/jac/article/59/5/833/729189)

#### **_Scoretools_**

[**MDCalc: HScore for Reactive Hemophagocytic Syndrome**](https://www.mdcalc.com/hscore-reactive-hemophagocytic-syndrome#use-cases)

[**MDCalc: Sequential Organ Failure Assessment (SOFA) Score**](https://www.mdcalc.com/sequential-organ-failure-assessment-sofa-score)

#### **_Courses_**

[**Karolinska Institute COVID-19 courses- preventing its spread and how to use protective equipment**](https://utbildning.ki.se/covid-19-web-courses-in-various-languages)

#### **_Trackers_**

* [**Johns Hopkins**](https://coronavirus.jhu.edu/map.html?fbclid=IwAR1R9BopZLi7WC_T-gvc7pApcdcfUgO1zH8xfQQRwQQiMl69ON2LtmwTG48)

#### **_Podcasts_**

[**EM:RAP**](https://covid.emrap.org/)

COVID-19-relaterat material

[**This week in virology**](http://www.microbe.tv/twiv/)

#### **_Youtube_**

[**Medcram: Coronavirus Pandemic Update 42: Immunity to COVID-19 and is Reinfection Possible?**](https://www.youtube.com/watch?feature=youtu.be&v=q4P91VrfPGw&app=desktop)

## 

![](/ethio_medical.jpg)

```bash
test 
test
```